North Shore Advanced Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 537 Patchogue Rd, Port Jefferson Station, NY 11776 Phone: 631-642-2020 Fax: 631-642-3938 |
Dr. Edward John Moylan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 537 Patchogue Road, Port Jefferson Station, NY 11776 Phone: 631-642-2020 Fax: 631-642-3938 |
Dr. Andrew Mulligan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1092 Route 112, Port Jefferson Station, NY 11776 Phone: 631-474-3937 Fax: 631-474-3966 |
Grueneyes Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1092 Route 112, Port Jefferson Station, NY 11776 Phone: 631-474-3937 Fax: 631-474-3966 |
Julie Demartini, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 500 Hallock Ave, Port Jefferson Station, NY 11776 Phone: 516-393-8907 |
Dr. Howard Kessler, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5330 Nesconset Hwy, Port Jefferson Station, NY 11776 Phone: 631-331-3883 Fax: 631-642-1506 |
Insight Vision Center Ltd Optometrist Medicare: Medicare Enrolled Practice Location: 5330 Nesconset Hwy, Port Jefferson Station, NY 11776 Phone: 631-331-3883 Fax: 631-642-1506 |
Svc Of Port Jefferson Station, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 524 Patchogue Rd, Port Jefferson Station, NY 11776 Phone: 631-476-4707 Fax: 631-727-2866 |
News Archive
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.
Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also associated with an increased risk of bleeding. It is paradoxical that elderly patients, the most likely population to develop CAD, are those that suffer most from bleeding complications.
Mathematicians at Michigan Technological University have developed powerful new tools for winnowing out the genes behind some of humanity's most intractable diseases.
KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced treatment of the first patient in a Phase 1 clinical trial of KB004, its first-in-class Humaneeredâ„¢ monoclonal antibody, in EphA3-expressing hematologic malignancies.
Gene hunters at Johns Hopkins have discovered a common genetic mutation that increases the risk of inheriting a particular birth defect not by the usual route of disrupting the gene's protein-making instructions, but by altering a regulatory region of the gene. Although the condition, called Hirschsprung disease, is rare, its complex genetics mimics that of more common diseases, such as diabetes and heart disease.
› Verified 5 days ago